Clinical Trial Update: Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating peginterferon alfa-2a plus ribavirin for genotype 2 chronic hepatitis C, focusing on treatment duration and ribavirin d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Chronic Hepatitis C | Phase 4 | Status: COMPLETED